Stockholm3 blood test detected 90% of aggressive prostate cancer cases compared to 74% for PSA tests in a study of over ...

Daniel W. Lin, MD, reviews new guidance on using MRI, biomarkers, and more, to improve the detection of prostate cancer.

Prostate cancer affects 1 in 8 men, but experts say it’s highly treatable when caught early. A survivor shares how PSA ...

When high-profile figures publicly discuss their prostate cancer, the public health impact can be immediate. The media ...

When high-profile figures publicly discuss their prostate cancer, the public health impact can be immediate. The media ...

About 4,500 men are diagnosed with prostate cancer in New Zealand every year, and more than 700 will die from it.

Millions of men face a decision about whether to be screened for prostate cancer. National guidelines say that decision ...

UPMC announced Tuesday that it will begin offering advanced prostate cancer treatment closer to home so patients don't have ...

If the US FDA approves it, aglatimagene immunotherapy may become the first new therapy for men with localized prostate cancer in the past 2 decades.

The major challenge in prostate cancer screening is not just to find more cancer cases, but to identify the cancers that are ...

LONDON, June 22 — Jeremy Clarkson has revealed he is officially in remission after battling an ...

In this video, Andre Kydd, MD, PhD, discusses highlights in the field of prostate cancer, including biomarkers of response in treatment and data on new classes of therapeutic agents, presented at ASCO ...